Free Trial

Electromed (ELMD) Competitors

Electromed logo
$20.41 +0.08 (+0.39%)
Closing price 05/29/2025 04:00 PM Eastern
Extended Trading
$20.38 -0.04 (-0.17%)
As of 05/29/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ELMD vs. IRMD, RXST, EMBC, BBNX, CBLL, NPCE, AVNS, DCTH, BFLY, and BVS

Should you be buying Electromed stock or one of its competitors? The main competitors of Electromed include Iradimed (IRMD), RxSight (RXST), Embecta (EMBC), Beta Bionics (BBNX), CeriBell (CBLL), NeuroPace (NPCE), Avanos Medical (AVNS), Delcath Systems (DCTH), Butterfly Network (BFLY), and Bioventus (BVS). These companies are all part of the "medical equipment" industry.

Electromed vs.

Electromed (NYSE:ELMD) and Iradimed (NASDAQ:IRMD) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.

Iradimed received 236 more outperform votes than Electromed when rated by MarketBeat users. However, 92.59% of users gave Electromed an outperform vote while only 65.58% of users gave Iradimed an outperform vote.

CompanyUnderperformOutperform
ElectromedOutperform Votes
25
92.59%
Underperform Votes
2
7.41%
IradimedOutperform Votes
261
65.58%
Underperform Votes
137
34.42%

Iradimed has a net margin of 26.26% compared to Electromed's net margin of 11.34%. Iradimed's return on equity of 24.12% beat Electromed's return on equity.

Company Net Margins Return on Equity Return on Assets
Electromed11.34% 15.71% 13.37%
Iradimed 26.26%24.12%21.20%

Electromed currently has a consensus target price of $38.00, indicating a potential upside of 86.18%. Iradimed has a consensus target price of $72.00, indicating a potential upside of 23.84%. Given Electromed's stronger consensus rating and higher probable upside, analysts plainly believe Electromed is more favorable than Iradimed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Electromed
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00
Iradimed
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Electromed and Electromed both had 4 articles in the media. Electromed's average media sentiment score of 1.34 beat Iradimed's score of 1.20 indicating that Electromed is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Electromed
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Iradimed
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Iradimed has higher revenue and earnings than Electromed. Electromed is trading at a lower price-to-earnings ratio than Iradimed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Electromed$61.44M2.79$5.15M$0.7925.84
Iradimed$75.15M9.84$19.23M$1.5537.51

40.8% of Electromed shares are owned by institutional investors. Comparatively, 92.3% of Iradimed shares are owned by institutional investors. 14.0% of Electromed shares are owned by company insiders. Comparatively, 36.8% of Iradimed shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Electromed has a beta of 0.46, meaning that its share price is 54% less volatile than the S&P 500. Comparatively, Iradimed has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500.

Summary

Iradimed beats Electromed on 13 of the 18 factors compared between the two stocks.

Get Electromed News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELMD vs. The Competition

MetricElectromedElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$171.16M$3.19B$5.38B$19.45B
Dividend YieldN/A1.81%5.28%3.90%
P/E Ratio27.2117.8626.9934.73
Price / Sales2.79161.07412.1741.78
Price / Cash41.3644.0938.2517.51
Price / Book4.003.786.844.74
Net Income$5.15M$94.03M$3.22B$1.02B
7 Day Performance3.87%0.63%2.47%1.52%
1 Month Performance-11.38%15.31%9.71%5.32%
1 Year Performance38.00%-9.69%20.95%6.34%

Electromed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELMD
Electromed
1.0882 of 5 stars
$20.41
+0.4%
$38.00
+86.2%
+38.9%$171.16M$61.44M27.21160Positive News
IRMD
Iradimed
4.7187 of 5 stars
$51.09
-2.3%
$72.00
+40.9%
+37.8%$649.61M$75.15M34.06110News Coverage
Positive News
RXST
RxSight
3.0537 of 5 stars
$15.68
-1.3%
$37.90
+141.7%
-73.1%$637.19M$148.31M-18.89220Positive News
Gap Up
EMBC
Embecta
4.8357 of 5 stars
$10.72
+2.0%
$19.33
+80.3%
-18.0%$626.51M$1.08B10.721,900Short Interest ↓
BBNX
Beta Bionics
N/A$14.43
-7.0%
$24.83
+72.1%
N/A$625.63M$69.83M0.00294
CBLL
CeriBell
2.8075 of 5 stars
$16.58
-3.9%
$32.50
+96.0%
N/A$599.25M$71.54M0.00N/APositive News
NPCE
NeuroPace
2.3513 of 5 stars
$17.68
-1.1%
$15.00
-15.2%
+94.5%$579.89M$84.31M-17.68170Trending News
Analyst Forecast
Analyst Revision
Gap Down
AVNS
Avanos Medical
2.6044 of 5 stars
$12.32
-1.3%
N/A-34.7%$569.50M$689.20M36.224,040Positive News
Analyst Revision
DCTH
Delcath Systems
3.6458 of 5 stars
$16.11
-0.2%
$24.00
+49.0%
+138.6%$561.05M$53.85M-11.9360Positive News
BFLY
Butterfly Network
1.965 of 5 stars
$2.18
+1.9%
$4.00
+83.5%
+144.0%$539.09M$85.63M-4.74460
BVS
Bioventus
3.1157 of 5 stars
$6.53
+0.3%
$14.33
+119.5%
-3.7%$536.40M$567.70M-10.701,200Positive News

Related Companies and Tools


This page (NYSE:ELMD) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners